News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
651,344 Results
Type
Article (46401)
Company Profile (131)
Press Release (604799)
Multimedia
Podcasts (115)
Webinars (17)
Section
Business (172225)
Career Advice (1708)
Deals (31942)
Drug Delivery (127)
Drug Development (79661)
Employer Resources (95)
FDA (17013)
Job Trends (13722)
News (309454)
Policy (34030)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (2590)
Academic (1)
Accelerated approval (34)
Adcomms (35)
Allergies (139)
Alliances (44706)
ALS (176)
Alzheimer's disease (1738)
Antibody-drug conjugate (ADC) (351)
Approvals (17214)
Artificial intelligence (534)
Autoimmune disease (154)
Automation (34)
Bankruptcy (296)
Best Places to Work (11201)
BIOSECURE Act (17)
Biosimilars (181)
Biotechnology (94)
Bladder cancer (154)
Brain cancer (64)
Breast cancer (659)
Cancer (4842)
Cardiovascular disease (412)
Career advice (1412)
Career pathing (28)
CAR-T (271)
CDC (33)
Celiac Disease (1)
Cell therapy (712)
Cervical cancer (33)
Clinical research (68127)
Collaboration (1724)
Company closure (4)
Compensation (1051)
Complete response letters (73)
COVID-19 (2576)
CRISPR (74)
C-suite (808)
Cystic fibrosis (149)
Data (6184)
Decentralized trials (2)
Denatured (24)
Depression (147)
Diabetes (517)
Diagnostics (6453)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (25)
Drug discovery (281)
Drug pricing (223)
Drug shortages (36)
Duchenne muscular dystrophy (230)
Earnings (71473)
Editorial (56)
Employer branding (15)
Employer resources (89)
Events (104140)
Executive appointments (927)
FDA (20186)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1387)
Gene editing (178)
Generative AI (48)
Gene therapy (579)
GLP-1 (1084)
Government (4823)
Grass and pollen (7)
Guidances (381)
Healthcare (18622)
HIV (60)
Huntington's disease (42)
IgA nephropathy (84)
Immunology and inflammation (263)
Immuno-oncology (60)
Indications (102)
Infectious disease (2830)
Inflammatory bowel disease (193)
Inflation Reduction Act (17)
Influenza (104)
Intellectual property (242)
Interviews (308)
IPO (15356)
IRA (60)
Job creations (2880)
Job search strategy (1183)
JPM (59)
Kidney cancer (16)
Labor market (43)
Layoffs (504)
Leadership (28)
Legal (7415)
Liver cancer (93)
Longevity (14)
Lung cancer (651)
Lymphoma (373)
Machine learning (43)
Management (34)
Manufacturing (754)
MASH (174)
Medical device (13036)
Medtech (13084)
Mergers & acquisitions (17649)
Metabolic disorders (1358)
Multiple sclerosis (165)
NASH (22)
Neurodegenerative disease (339)
Neuropsychiatric disorders (99)
Neuroscience (3019)
Neurotech (1)
NextGen: Class of 2026 (6267)
Non-profit (4380)
Now hiring (53)
Obesity (659)
Opinion (298)
Ovarian cancer (165)
Pain (212)
Pancreatic cancer (224)
Parkinson's disease (288)
Partnered (32)
Patents (481)
Patient recruitment (478)
Peanut (52)
People (51615)
Pharmaceutical (31)
Pharmacy benefit managers (32)
Phase 1 (20896)
Phase 2 (29761)
Phase 3 (22721)
Pipeline (5126)
Policy (300)
Postmarket research (2874)
Preclinical (8868)
Press Release (64)
Prostate cancer (235)
Psychedelics (53)
Radiopharmaceuticals (274)
Rare diseases (869)
Real estate (4705)
Recruiting (38)
Regulatory (26353)
Reports (25)
Research institute (2379)
Resumes & cover letters (299)
Rett syndrome (27)
RNA editing (12)
RSV (68)
Schizophrenia (157)
Series A (235)
Series B (174)
Service/supplier (7)
Sickle cell disease (93)
Special edition (17)
Spinal muscular atrophy (170)
Sponsored (34)
Startups (3132)
State (2)
Stomach cancer (17)
Supply chain (102)
Tariffs (88)
The Weekly (89)
Vaccines (880)
Venture capital (78)
Weight loss (448)
Women's health (72)
Worklife (12)
Date
Today (116)
Last 7 days (610)
Last 30 days (2130)
Last 365 days (29872)
2026 (3003)
2025 (30145)
2024 (34849)
2023 (39701)
2022 (49947)
2021 (54073)
2020 (52688)
2019 (45674)
2018 (34615)
2017 (31643)
2016 (29849)
2015 (34515)
2014 (25624)
2013 (21107)
2012 (22664)
2011 (23967)
2010 (21620)
Location
Africa (733)
Alabama (86)
Alaska (5)
Arizona (218)
Arkansas (11)
Asia (39062)
Australia (6460)
California (10836)
Canada (3211)
China (1124)
Colorado (459)
Connecticut (466)
Delaware (334)
Europe (89113)
Florida (1641)
Georgia (353)
Hawaii (3)
Idaho (48)
Illinois (847)
India (65)
Indiana (476)
Iowa (20)
Japan (425)
Kansas (120)
Kentucky (32)
Louisiana (27)
Maine (83)
Maryland (1354)
Massachusetts (7839)
Michigan (307)
Minnesota (579)
Mississippi (4)
Missouri (130)
Montana (31)
Nebraska (23)
Nevada (112)
New Hampshire (83)
New Jersey (2969)
New Mexico (26)
New York (2912)
North Carolina (1459)
North Dakota (8)
Northern California (5313)
Ohio (322)
Oklahoma (19)
Oregon (35)
Pennsylvania (2194)
Puerto Rico (23)
Rhode Island (41)
South America (1005)
South Carolina (38)
South Dakota (1)
Southern California (4254)
Tennessee (166)
Texas (1652)
United States (38674)
Utah (326)
Virginia (255)
Washington D.C. (73)
Washington State (860)
West Virginia (2)
Wisconsin (103)
Wyoming (2)
651,344 Results for "drug information association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
Amgen Will Not Heed FDA Request To Withdraw Rare Disease Drug Tavneos
After review, Amgen is certain that Tavneos is effective and has a favorable benefit-risk profile. The company informed the FDA on January 28 that they would not pull the drug.
February 4, 2026
·
2 min read
·
Annalee Armstrong
Insights
From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era
Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like MPS II moving into the spotlight.
February 4, 2026
·
3 min read
·
Jennifer Smith-Parker
Manufacturing
Eli Lilly Commits $3.5B To Build Injectable Obesity Drug Plant in PA
The facility, which is part of Lilly’s $50 billion reshoring drive, will make obesity drugs such as tirzepatide and retatrutide when it starts operations in 2031.
February 2, 2026
·
2 min read
·
Nick Paul Taylor
Weight loss
Novo’s Next-Gen Obesity Drug Beats Wegovy on Blood Sugar Control in Phase III
While CagriSema bested Novo Nordisk’s Wegovy on blood sugar control in a late-stage trial, the next-gen weight loss drug still has not met the pharma’s 25% weight loss goal.
February 3, 2026
·
2 min read
·
Tristan Manalac
Earnings
Insmed Jumps on ‘Blowout’ Sales Beat for Bronchiectasis Drug Brinsupri
Insmed’s freshly approved lung condition drug soared past sales expectations for 2025, netting $144.6 million in its first full quarter of sales.
January 9, 2026
·
1 min read
·
Dan Samorodnitsky
Drug pricing
Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026
Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller biotechs continue to hang in limbo.
January 6, 2026
·
5 min read
·
Annalee Armstrong
Policy
Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech
Acadia Pharma’s Catherine Owen Adams is one of the founders of a group of small- to mid-cap biotechs advocating against a ‘peanut butter blanket’ approach to drug pricing for small companies.
January 13, 2026
·
3 min read
·
Annalee Armstrong
Cancer
Gilead Keeps Dealing With $300M OncoNano Drug Delivery Cancer Pact
OncoNano’s platform, called ON-BOARD, packages drugs in pH-sensitive micelles that ensure their specific delivery near tumors, while also preventing systemic exposure.
January 6, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Wellgistics Health Enters into Smart Contract Services Agreement with DataVault AI to Develop Patented PharmacyChain(TM) Manufacturer-to-Patient Blockchain-Enabled Tracking & Dispensing Platform for Prescription Drug Market
Powered by DataVault AI’s High-Performance Computing & Information Exchange, Data Monetization for Traditional and Compound Pharmacies is Set to Become a Reality in the $639 Billion Prescription Drug Market, with Beta Testing Expected in First Half of 2026
October 27, 2025
·
7 min read
Drug pricing
Pfizer Leads Industry-Wide Surge in Drug Prices for 2026 Despite Political Pressure
More than a dozen pharmas have recently struck deals with the White House to lower drug prices. Nevertheless, drugmakers reportedly plan to raise the U.S. prices of at least 350 branded medications.
January 2, 2026
·
2 min read
·
Nick Paul Taylor
1 of 65,135
Next
